Increased mean corpuscular volume as a predictor of response during bevacizumab treatment

by Zygulska Lidia Aneta, Krzemieniecki Krzysztof
Published 2012-01-01

Targeting of solid tumors and blood malignancies by antibody-based therapies — EGFR-pathway as an example

by Krzemieniecki Krzysztof, Szpyt Elzbieta, Rashedi Iran, Gawron Katarzyna, Los Marek
Published 2006-06-01